WHO ICTRP trial
Pilot trial assessment of the diagnostic value of Cu64 SAR-Bombesin PET/CT…
ACTRN12619001383156 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12619001383156 |
|---|---|
| Public title | Pilot trial assessment of the diagnostic value of Cu64 SAR-Bombesin PET/CT imaging for staging of ER/PR + HER2- breast cancer patients with metastatic disease in comparison with conventional imaging (CT, bone scan and 18F-FDG PET/CT) |
| Scientific title | Pilot trial assessment of the diagnostic value of Cu64 SAR-Bombesin PET/CT imaging for staging of ER/PR + HER2- breast cancer patients with metastatic disease in comparison with conventional imaging (CT, bone scan and 18F-FDG PET/CT) |
| Primary sponsor | St Vincent's Hospital |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | Australia |
| Conditions | Hormone Positive Metastatic Breast Cancer; Hormone Positive Metastatic Breast Cancer;Cancer - Breast |
| Interventions | The patient will be given an appointment to come to the St Vincent's Hospital Sydney Department of Theranostics and Nuclear Medicine Department. Pre-intervention checks (i.e. baseline blood tests, baseline vitals, and 12 lead ECG) will be… |
| Registration date | Oct 10, 2019 |
| Target size | 10 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: